We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Microplastic Particles Detected in Fetal Cord Blood, Placenta, and Meconium: A Pilot Study of Nine Mother–Infant Pairs in South China
Summary
In a pilot study of nine mother-infant pairs in China, researchers detected microplastics in the placenta, umbilical cord blood, and first stool of newborns, with meconium (baby's first stool) containing the most particles. This provides evidence that microplastics can transfer from mother to baby during pregnancy, raising concerns about plastic exposure during the most vulnerable stage of human development.
Microplastics (MPs) are emerging environmental pollutants. Pregnancy and infancy are sensitive windows for environmental exposure. However, few studies have investigated the presence of MPs in mother-infant pairs, or the exposure source. In this study, nine mother-infant pairs were recruited, and samples of placenta, cord blood, and meconium were collected. Information about the living environment and dietary habits were collected to determine the source of exposure during pregnancy. Micro-Raman spectroscopy was applied to identify MPs. In total, 9, 4, and 14 types of MPs were identified in the placenta, cord blood, and meconium samples, with particle counts of 34, 14, and 80, respectively. More than 80.47% of MPs detected in samples had a size of 100-400 μm. The abundance of MPs exhibited the order of meconium > placenta > cord blood (Hc = 14.959, p < 0.01). We found that the abundance of MPs in meconium from women who drank tea ≥ 3 times/week during pregnancy was lower than in those who drank less (p = 0.048). Our study presents evidence of MPs transfer via the placenta-cord blood-meconium pathway. We also found that the habit of drinking tea among pregnant women might be related to the abundance of MPs in meconium.
Sign in to start a discussion.
More Papers Like This
Detection of Microplastic in Human Placenta and Meconium in a Clinical Setting
Researchers detected microplastic particles larger than 50 micrometers in human placenta and meconium (a baby's first stool) collected during cesarean deliveries. This is significant because it provides direct evidence that microplastics are present in the womb and are being passed to babies before and during birth. The study emphasizes the need for careful contamination controls in clinical studies and calls for further research on nano-sized plastics in human tissue.
Detection of various microplastics in placentas, meconium, infant feces, breastmilk and infant formula: A pilot prospective study
In a pilot study of 18 mother-infant pairs, researchers detected microplastics in placentas, meconium (first stool), infant feces, breast milk, and infant formula. The finding of microplastics in breast milk and formula means that infants are exposed to microplastics from their earliest feedings, both natural and artificial. This study reveals that microplastic exposure begins before birth and continues through infancy, a critical period of development.
The Association Between Microplastics and Microbiota in Placentas and Meconium: The First Evidence in Humans
Researchers analyzed placentas and meconium from 18 mother-infant pairs in Shanghai and found microplastics present in both, providing some of the first direct evidence of microplastic exposure during pregnancy and at birth. They also discovered correlations between microplastic presence and changes in microbial communities in these tissues. The study raises important questions about whether early-life microplastic exposure could influence infant health and development.
Detection and quantification of microplastics in meconium by pyrolysis-gas chromatography/mass spectrometry (Py-GC/MS)
Scientists developed a method to detect and measure eight types of microplastics in meconium, the first stool a newborn passes after birth. They found microplastics including polyethylene, polypropylene, and polystyrene in the samples, confirming that babies are exposed to microplastics before or during birth. This study provides direct evidence that microplastics reach the human body at the very earliest stage of life.
Microplastics in the Perinatal Period: Emerging Evidence on Maternal Exposure, Placental Transfer, and Fetal Health Outcomes
This review summarizes emerging evidence that microplastics can cross the placenta and reach developing babies, having been detected in maternal blood, placental tissue, amniotic fluid, cord blood, and breast milk. The tiny plastic particles may damage the placenta, disrupt hormones, alter immune responses, and potentially affect fetal growth and brain development. While more research is needed, the findings raise serious concerns about microplastic exposure during pregnancy and its implications for infant health.